Ryoichi_Ishibashi

Ryoichi Ishibashi MD, PhD

Kimitsu Chuo Hospital

Appearances

Preadministration of SGLT2 Inhibitor Reduces Frequency of Anti-VEGF Agent Administration in Patients with Mild Diabetic Macular Edema—A Multicenter Randomized Controlled Open-Label Trial
Date
June 21, 2024
Speaker
Ryoichi Ishibashi, MD, PhD
Kimitsu Chuo Hospital